EP1175215A2 - L'osanetant dans le traitement des troubles de l'humeur - Google Patents
L'osanetant dans le traitement des troubles de l'humeurInfo
- Publication number
- EP1175215A2 EP1175215A2 EP00918941A EP00918941A EP1175215A2 EP 1175215 A2 EP1175215 A2 EP 1175215A2 EP 00918941 A EP00918941 A EP 00918941A EP 00918941 A EP00918941 A EP 00918941A EP 1175215 A2 EP1175215 A2 EP 1175215A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- osanetant
- treatment
- disorders
- mood disorders
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9904699 | 1999-04-13 | ||
FR9904699A FR2792199B3 (fr) | 1999-04-13 | 1999-04-13 | Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur |
PCT/FR2000/000924 WO2000061125A2 (fr) | 1999-04-13 | 2000-04-11 | L'osanetant dans le traitement des troubles de l'humeur |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1175215A2 true EP1175215A2 (fr) | 2002-01-30 |
Family
ID=9544412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00918941A Withdrawn EP1175215A2 (fr) | 1999-04-13 | 2000-04-11 | L'osanetant dans le traitement des troubles de l'humeur |
Country Status (24)
Country | Link |
---|---|
US (1) | US6420388B1 (no) |
EP (1) | EP1175215A2 (no) |
JP (1) | JP2002541190A (no) |
KR (1) | KR20010105418A (no) |
CN (1) | CN1354662A (no) |
AR (1) | AR023452A1 (no) |
AU (1) | AU3971600A (no) |
BR (1) | BR0009704A (no) |
CA (1) | CA2369638A1 (no) |
CZ (1) | CZ20013645A3 (no) |
EE (1) | EE200100527A (no) |
FR (1) | FR2792199B3 (no) |
HR (1) | HRP20010741A2 (no) |
HU (1) | HUP0200655A3 (no) |
ID (1) | ID30458A (no) |
IS (1) | IS6098A (no) |
MX (1) | MXPA01010340A (no) |
NO (1) | NO20014953L (no) |
PE (1) | PE20010032A1 (no) |
PL (1) | PL351554A1 (no) |
SK (1) | SK14552001A3 (no) |
TR (1) | TR200102930T2 (no) |
WO (1) | WO2000061125A2 (no) |
ZA (1) | ZA200108289B (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE367811T1 (de) * | 2000-06-12 | 2007-08-15 | Univ Rochester | Methode zur behandlung von hitzewallungen, durch verwendung eines tachikinin-rezeptor antagonisten |
TWI329649B (en) * | 2003-12-22 | 2010-09-01 | Glaxo Group Ltd | Immunoglobulins |
US20070244152A1 (en) * | 2004-03-25 | 2007-10-18 | Lowy Martin T | Use of an Nk3 Antagonist for the Treatment of Bipolar Disorders |
WO2006098488A1 (ja) | 2005-03-15 | 2006-09-21 | Sumitomo Chemical Company, Limited | 気分障害による疾患症状を改善させる方法 |
JP2006320201A (ja) * | 2005-05-17 | 2006-11-30 | Sumitomo Chemical Co Ltd | 気分障害又は関連障害による疾患症状を改善させる方法 |
GB0525662D0 (en) | 2005-12-16 | 2006-01-25 | Glaxo Group Ltd | Immunoglobulins |
WO2015200594A2 (en) * | 2014-06-25 | 2015-12-30 | Emory University | Methods of managing conditioned fear with neurokinin receptor antagonists |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2719311B1 (fr) | 1994-03-18 | 1998-06-26 | Sanofi Sa | Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic. |
FR2729954B1 (fr) * | 1995-01-30 | 1997-08-01 | Sanofi Sa | Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
FR2738819B1 (fr) | 1995-09-14 | 1997-12-05 | Sanofi Sa | Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant |
AU4176997A (en) | 1996-09-16 | 1998-04-02 | Warner-Lambert Company | 3-alkyl-3-phenyl-piperidines |
-
1999
- 1999-04-13 FR FR9904699A patent/FR2792199B3/fr not_active Expired - Fee Related
-
2000
- 2000-04-11 JP JP2000610458A patent/JP2002541190A/ja not_active Withdrawn
- 2000-04-11 EP EP00918941A patent/EP1175215A2/fr not_active Withdrawn
- 2000-04-11 ID IDW00200102144A patent/ID30458A/id unknown
- 2000-04-11 TR TR2001/02930T patent/TR200102930T2/xx unknown
- 2000-04-11 MX MXPA01010340A patent/MXPA01010340A/es not_active Application Discontinuation
- 2000-04-11 CZ CZ20013645A patent/CZ20013645A3/cs unknown
- 2000-04-11 EE EEP200100527A patent/EE200100527A/xx unknown
- 2000-04-11 SK SK1455-2001A patent/SK14552001A3/sk unknown
- 2000-04-11 AU AU39716/00A patent/AU3971600A/en not_active Abandoned
- 2000-04-11 BR BR0009704-7A patent/BR0009704A/pt not_active Application Discontinuation
- 2000-04-11 US US09/958,266 patent/US6420388B1/en not_active Expired - Fee Related
- 2000-04-11 PL PL00351554A patent/PL351554A1/xx not_active Application Discontinuation
- 2000-04-11 KR KR1020017012990A patent/KR20010105418A/ko not_active Application Discontinuation
- 2000-04-11 WO PCT/FR2000/000924 patent/WO2000061125A2/fr not_active Application Discontinuation
- 2000-04-11 CN CN00806091A patent/CN1354662A/zh active Pending
- 2000-04-11 CA CA002369638A patent/CA2369638A1/en not_active Abandoned
- 2000-04-11 HU HU0200655A patent/HUP0200655A3/hu unknown
- 2000-04-12 AR ARP000101670A patent/AR023452A1/es unknown
- 2000-04-13 PE PE2000000343A patent/PE20010032A1/es not_active Application Discontinuation
-
2001
- 2001-09-28 IS IS6098A patent/IS6098A/is unknown
- 2001-10-09 ZA ZA200108289A patent/ZA200108289B/xx unknown
- 2001-10-11 NO NO20014953A patent/NO20014953L/no not_active Application Discontinuation
- 2001-10-12 HR HR20010741A patent/HRP20010741A2/hr not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO0061125A2 * |
Also Published As
Publication number | Publication date |
---|---|
AU3971600A (en) | 2000-11-14 |
CN1354662A (zh) | 2002-06-19 |
EE200100527A (et) | 2002-12-16 |
FR2792199B3 (fr) | 2001-05-18 |
WO2000061125A2 (fr) | 2000-10-19 |
KR20010105418A (ko) | 2001-11-28 |
CA2369638A1 (en) | 2000-10-19 |
HUP0200655A3 (en) | 2002-11-28 |
JP2002541190A (ja) | 2002-12-03 |
HUP0200655A2 (hu) | 2002-07-29 |
NO20014953L (no) | 2001-12-11 |
CZ20013645A3 (cs) | 2002-01-16 |
TR200102930T2 (tr) | 2002-04-22 |
MXPA01010340A (es) | 2002-05-06 |
PL351554A1 (en) | 2003-05-05 |
BR0009704A (pt) | 2002-01-08 |
FR2792199A1 (fr) | 2000-10-20 |
ZA200108289B (en) | 2002-12-24 |
AR023452A1 (es) | 2002-09-04 |
IS6098A (is) | 2001-09-28 |
ID30458A (id) | 2001-12-06 |
NO20014953D0 (no) | 2001-10-11 |
HRP20010741A2 (en) | 2002-10-31 |
US6420388B1 (en) | 2002-07-16 |
WO2000061125A3 (fr) | 2001-04-19 |
SK14552001A3 (sk) | 2002-02-05 |
PE20010032A1 (es) | 2001-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5075338A (en) | Method of treatment of learning deficiency | |
EP1221952B1 (fr) | UTILISATION D'UN ANTAGONISTE DES RECEPTEURS AUX CANNABINOiDES CENTRAUX POUR LA PREPARATION DE MEDICAMENTS | |
CH672068A5 (no) | ||
EP0369887B1 (fr) | Utilisation de trifluorométhylphényltétrahydropyridines pour la préparation de médicaments destinés à combattre les troubles anxio-dépressifs | |
US5220068A (en) | Psychostimulant agent | |
FR2837706A1 (fr) | Utilisation d'un antagoniste des recepteurs aux cannabinoides cb1 pour la preparation de medicaments utiles pour traiter les dysfonctionnements sexuels et/ou ameliorer les performances sexuelles | |
EP1173179A2 (fr) | Utilisation du saredutant et de ses sels pharmaceutiquement acceptables dans le traitement ou la prevention des troubles depressifs majeurs | |
WO2000061125A2 (fr) | L'osanetant dans le traitement des troubles de l'humeur | |
EP0429360B1 (fr) | Inhibition du syndrome d'abstinence | |
EP0412901B1 (fr) | Utilisation de trifluorométhyl-phényltétrahydropyridines pour la préparation de médicaments destinés à combattre les troubles de la motricité intestinale | |
CH679553A5 (no) | ||
KR100906893B1 (ko) | 피페리딘-2,6-디온 바이설페이트 염 및 스트레스 관련 정동 장애의 치료를 위한 이의 용도 | |
CH678149A5 (no) | ||
FR2579893A1 (no) | ||
KR20010110798A (ko) | 신경퇴화의 치료방법 | |
WO2000066117A1 (fr) | Utilisation du (2s)-1- [(2r,3s)-5- chloro-3- (2-chlorophenyl)-1- (3,4-dimethoxybenzenesulfonyl)- 3-hydroxy-2,3- dihydro-1h-indole-2-carbonyl] pyrrolidine- 2-carboxamide pour la preparation de medicaments utiles dans le traitement du phenomene de raynaud | |
JP2610735B2 (ja) | 抗鬱剤および抗ストレス剤組成物 | |
FR2915100A1 (fr) | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxalide pour le traitement des desordres moteurs lies a la maladie de parkinson | |
CA2658614A1 (fr) | Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine | |
FR2912058A1 (fr) | Utilisation d'un compose antagoniste des recepteurs nk2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles | |
FR2711527A1 (fr) | Utilisation de l'acriflavine comme agent anti HIV. | |
FR2527077A1 (fr) | Nouveau medicament a base d'un anti-depresseur et d'un alcaloide ergopeptidique | |
EP2146713A2 (fr) | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-4- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens | |
FR2585573A1 (fr) | Medicament pour prevenir l'abus d'alcool | |
FR2740343A1 (fr) | Utilisation de la 1-(2-napht-2-yl-ethyl)-4- (3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de la sclerose laterale amyotrophique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
17P | Request for examination filed |
Effective date: 20011113 |
|
17Q | First examination report despatched |
Effective date: 20031024 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040308 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1041822 Country of ref document: HK |